103 related articles for article (PubMed ID: 18192035)
1. Adiponectin is released from the heart in patients with heart failure.
Takano H; Obata JE; Kodama Y; Kitta Y; Nakamura T; Mende A; Kawabata K; Saito Y; Fujioka D; Kobayashi T; Yano T; Sano K; Kugiyama K
Int J Cardiol; 2009 Feb; 132(2):221-6. PubMed ID: 18192035
[TBL] [Abstract][Full Text] [Related]
2. Adiponectin acts as a positive indicator of left ventricular diastolic dysfunction in patients with hypertrophic cardiomyopathy.
Unno K; Shibata R; Izawa H; Hirashiki A; Murase Y; Yamada T; Kobayashi M; Noda A; Nagata K; Ouchi N; Murohara T
Heart; 2010 Mar; 96(5):357-61. PubMed ID: 19648128
[TBL] [Abstract][Full Text] [Related]
3. Increased adiponectin level in parallel with increased NT-pro BNP in patients with severe heart failure in the elderly: A hospital cohort study.
Haugen E; Furukawa Y; Isic A; Fu M
Int J Cardiol; 2008 Apr; 125(2):216-9. PubMed ID: 18234365
[TBL] [Abstract][Full Text] [Related]
4. Increase in serum adiponectin concentration in patients with heart failure and cachexia: relationship with leptin, other cytokines, and B-type natriuretic peptide.
McEntegart MB; Awede B; Petrie MC; Sattar N; Dunn FG; MacFarlane NG; McMurray JJ
Eur Heart J; 2007 Apr; 28(7):829-35. PubMed ID: 17403719
[TBL] [Abstract][Full Text] [Related]
5. Plasma levels of adrenomedullin and atrial natriuretic peptide in patients with congestive heart failure of various etiologies.
Randa Abdel Kader M; Grace BD; Badawi NE
Ital J Biochem; 2007 Mar; 56(1):18-27. PubMed ID: 17511350
[TBL] [Abstract][Full Text] [Related]
6. Associations between endothelin-1 and adiponectin in chronic heart failure.
Yin WH; Chen YH; Wei J; Jen HL; Huang WP; Young MS; Chen DC; Liu PL
Cardiology; 2011; 118(4):207-16. PubMed ID: 21701170
[TBL] [Abstract][Full Text] [Related]
7. [Serum adiponectin level in patients of chronic pulmonary heart disease with cardiac failure].
Shi HF; Ding YP; He HW
Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(36):2544-6. PubMed ID: 19080646
[TBL] [Abstract][Full Text] [Related]
8. Relation between CD4+ T-cell activation and severity of chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
Fukunaga T; Soejima H; Irie A; Sugamura K; Oe Y; Tanaka T; Nagayoshi Y; Kaikita K; Sugiyama S; Yoshimura M; Nishimura Y; Ogawa H
Am J Cardiol; 2007 Aug; 100(3):483-8. PubMed ID: 17659933
[TBL] [Abstract][Full Text] [Related]
9. Serial changes in adiponectin and BNP in ACS patients: paradoxical associations with each other and with prognosis.
Ang DS; Welsh P; Watt P; Nelson SM; Struthers A; Sattar N
Clin Sci (Lond); 2009 Jun; 117(1):41-8. PubMed ID: 19175359
[TBL] [Abstract][Full Text] [Related]
10. Dynamic changes in plasma total and high molecular weight adiponectin levels in acute heart failure.
Ohara T; Hashimura K; Asakura M; Ogai A; Amaki M; Hasegawa T; Kanzaki H; Sonoda M; Nishizawa H; Funahashi T; Kitakaze M
J Cardiol; 2011 Sep; 58(2):181-90. PubMed ID: 21824750
[TBL] [Abstract][Full Text] [Related]
11. Association of adiponectin with peripheral muscle status in elderly patients with heart failure.
Loncar G; Bozic B; von Haehling S; Düngen HD; Prodanovic N; Lainscak M; Arandjelovic A; Dimkovic S; Radojicic Z; Popovic V
Eur J Intern Med; 2013 Dec; 24(8):818-23. PubMed ID: 24095654
[TBL] [Abstract][Full Text] [Related]
12. Natriuretic peptides enhance the production of adiponectin in human adipocytes and in patients with chronic heart failure.
Tsukamoto O; Fujita M; Kato M; Yamazaki S; Asano Y; Ogai A; Okazaki H; Asai M; Nagamachi Y; Maeda N; Shintani Y; Minamino T; Asakura M; Kishimoto I; Funahashi T; Tomoike H; Kitakaze M
J Am Coll Cardiol; 2009 Jun; 53(22):2070-7. PubMed ID: 19477358
[TBL] [Abstract][Full Text] [Related]
13. Regional heterogeneity of decreased myocardial norepinephrine and increased lipid peroxidation levels in patients with end-stage failing heart secondary to dilated or ischemic cardiomyopathy.
Rochette L; Tatou E; Vergely C; Maupoil V; Bouchot O; Mossiat C; Jazayeri S; Benkhadra S; Brenot R; Girard C; David M
J Heart Lung Transplant; 2008 Jul; 27(7):767-74. PubMed ID: 18582807
[TBL] [Abstract][Full Text] [Related]
14. The acute effect of Metoprolol upon NT-proBNP level in patients with congestive heart failure.
Zdrenghea D; Pop D; Ilea M; Bodisz G; Mălai A; Zdrenghea M
Rom J Intern Med; 2009; 47(1):35-40. PubMed ID: 19886067
[TBL] [Abstract][Full Text] [Related]
15. Epicardial adipose tissue adiponectin expression is related to intracoronary adiponectin levels.
Iacobellis G; di Gioia CR; Cotesta D; Petramala L; Travaglini C; De Santis V; Vitale D; Tritapepe L; Letizia C
Horm Metab Res; 2009 Mar; 41(3):227-31. PubMed ID: 19003726
[TBL] [Abstract][Full Text] [Related]
16. Blood dendritic cell levels and phenotypic characteristics in relation to etiology of end-stage heart failure: implications for dilated cardiomyopathy.
Athanassopoulos P; Balk AH; Vaessen LM; Caliskan K; Takkenberg JJ; Weimar W; Bogers AJ
Int J Cardiol; 2009 Jan; 131(2):246-56. PubMed ID: 18243370
[TBL] [Abstract][Full Text] [Related]
17. Cardiac peptides during exercise test in ischemic and non-ischemic heart failure patients.
Ilea M; Zdrenghea D; Bodisz G; Mălai A; Gheorghiu L; Predescu D; Beudean M; Ossian V; Gligor E; Vlad C; Pop D; Bogdan E; Roşu R
Rom J Intern Med; 2008; 46(1):63-8. PubMed ID: 19157272
[TBL] [Abstract][Full Text] [Related]
18. Risk stratification of mortality in patients with heart failure and left ventricular ejection fraction >35%.
Cygankiewicz I; Zareba W; Vazquez R; Bayes-Genis A; Pascual D; Macaya C; Almendral J; Fiol M; Bardaji A; Gonzalez-Juanatey JR; Nieto V; Valdes M; Cinca J; de Luna AB;
Am J Cardiol; 2009 Apr; 103(7):1003-10. PubMed ID: 19327431
[TBL] [Abstract][Full Text] [Related]
19. Remission of left ventricular systolic dysfunction and of heart failure symptoms after cardiac resynchronization therapy: temporal pattern and clinical predictors.
Gasparini M; Regoli F; Ceriotti C; Galimberti P; Bragato R; De Vita S; Pini D; Andreuzzi B; Mangiavacchi M; Klersy C
Am Heart J; 2008 Mar; 155(3):507-14. PubMed ID: 18294488
[TBL] [Abstract][Full Text] [Related]
20. Distinct myocardial effects of beta-blocker therapy in heart failure with normal and reduced left ventricular ejection fraction.
Hamdani N; Paulus WJ; van Heerebeek L; Borbély A; Boontje NM; Zuidwijk MJ; Bronzwaer JG; Simonides WS; Niessen HW; Stienen GJ; van der Velden J
Eur Heart J; 2009 Aug; 30(15):1863-72. PubMed ID: 19487234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
